R. Paulus

Jose Belderbos, Walter J Curran, Rodrigo Arriagada, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

R. Arriagada, J. Pignon, S. Mandrekar, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704.

S. Horvath, D. Seligson, H. Reber, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung.

L. Wilson, H. Choy, M. Suntharalingam, 2012, International journal of radiation oncology, biology, physics.

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

Benjamin Movsas, Walter J Curran, Elizabeth Gore, 2011, Journal of the National Cancer Institute.

Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214.

H. Choy, B. Movsas, A. Sun, 2013, International journal of radiation oncology, biology, physics.

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.

J. Galvin, P. Iyengar, H. Choy, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.

W. Curran, H. Choy, J. Sloan, 2016, JAMA oncology.

Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive‐Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937

R. Hales, P. Iyengar, J. Bradley, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer.

Joe Y. Chang, Anurag K. Singh, P. Iyengar, 2017, International journal of radiation oncology, biology, physics.

Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.

D. Ettinger, W. Curran, J. Bradley, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.

K. Forster, P. Iyengar, H. Choy, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.

D. Low, H. Sandler, M. Amin, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617

W. Curran, P. Iyengar, H. Choy, 2021, Cancers.

Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the radiation therapy oncology group (RTOG) database.

Maria Werner-Wasik, Walter J Curran, W. Curran, 2011, Clinical lung cancer.

Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer: The NRG-LU001 Phase 2 Randomized Clinical Trial.

J. Bradley, J. Erasmus, R. Mcgarry, 2021, JAMA oncology.

Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non-small cell lung cancer.

M. Suntharalingam, B. Loo, J. Bradley, 2020, The Journal of thoracic and cardiovascular surgery.

Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non–Small Cell Lung Cancer: NRG Oncology RTOG 0839

B. Loo, M. Diehn, J. Bradley, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group.

Benjamin Movsas, Walter J Curran, Kyounghwa Bae, 2012, International journal of radiation oncology, biology, physics.

Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA/B non-small-cell lung cancer: RTOG 0324.

W. Curran, H. Choy, R. Herbst, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Defining Local-Regional Control and Its Importance in Locally Advanced Non-small Cell Lung Carcinoma

Benjamin Movsas, Walter J. Curran, Hak Choy, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: a secondary analysis of RTOG 0324.

W. Curran, H. Choy, F. Hirsch, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Higher Radiation Dose to Immune System is Correlated With Poorer Survival in Patients With Stage III Non–small Cell Lung Cancer: A Secondary Study of a Phase 3 Cooperative Group Trial (NRG Oncology RTOG 0617)

W. Curran, P. Iyengar, H. Choy, 2017 .

Impact of gender, partner status, and race on locoregional failure and overall survival in head and neck cancer patients in three radiation therapy oncology group trials.

A. Garden, K. Bae, T. Dilling, 2011, International journal of radiation oncology, biology, physics.

Clinical prognostic model for older patients with advanced non-small cell lung cancer.

H. Cohen, J. Bradley, K. Kelly, 2019, Journal of geriatric oncology.

Cost Effectiveness of Modified Fractionation Radiotherapy versus Conventional Radiotherapy for Unresected Non–Small-Cell Lung Cancer Patients

H. Choy, R. Arriagada, J. Pignon, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials.

H. Sandler, E. Horwitz, T. Pisansky, 2019, International journal of radiation oncology, biology, physics.

MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.

Kyounghwa Bae, Alan Pollack, D. Grignon, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801.

J. Bradley, R. Komaki, Y. Lawrence, 2013, Lung cancer.

Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer.

J. Galvin, R. Timmerman, L. Papiez, 2007, International journal of radiation oncology, biology, physics.

A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617.

W. Curran, K. Forster, H. Choy, 2013 .

Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancer.

C. Willett, N. Hanna, R. Paulus, 2013, International journal of radiation oncology, biology, physics.

RTOG 0229: A Phase II Trial of Neoadjuvant Therapy with Concurrent Chemotherapy and Full Dose Radiotherapy (XRT) followed by Resection and Consolidative Therapy for LA-NSCLC

H. Choy, M. Suntharalingam, M. Edelman, 2010 .

A BELGIAN REGISTRY OF INTERLEUKIN-2 ADMINISTRATION FOR TREATMENT OF METASTATIC RENAL CELL CANCER AND CONFRONTATION WITH LITERATURE DATA

R. Paulus, S. Rottey, L. Duck, 2007, Acta clinica Belgica.

Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239.

D. Ettinger, W. Curran, H. Choy, 2012, International journal of radiation oncology, biology, physics.

NRG-RTOG 1106/ACRIN 6697: A phase IIR trial of standard versus adaptive (mid-treatment PET-based) chemoradiotherapy for stage III NSCLC—Results and comparison to NRG-RTOG 0617 (non-personalized RT dose escalation).

B. Loo, J. Bradley, J. Hayman, 2021 .

Outcomes for Favorable and Unfavorable Intermediate Risk Prostate Cancer Patients Receiving Radiation Therapy With or Without Short-term Androgen Deprivation Therapy

J. Efstathiou, R. Paulus, J. Voog, 2015 .

Development and Implementation of a Multisite Registry Using Structured Templates for Actionable Findings in the Kidney.

T. Cook, R. Paulus, Laura B Gillis, 2022, Journal of the American College of Radiology : JACR.

RTOG 0324: A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients with stage IIIA/B non-small cell lung cancer (NSCLC)--Association between EGFR gene copy number and patients' outcome

W. Curran, H. Choy, F. Hirsch, 2008 .

Feasibility of economic analysis of Radiation Therapy Oncology Group (RTOG) 91-11 using Medicare data.

K. Ang, J. Cooper, Mythreyi Bhargavan, 2011, International journal of radiation oncology, biology, physics.

Toxicity Analysis of RTOG 0236 Using Stereotactic Body Radiation Therapy to Treat Medically Inoperable Early Stage Lung Cancer Patients

J. Galvin, H. Choy, R. Timmerman, 2007 .

In Reply to Healy

R. Paulus, M. Machtay, 2012 .

No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy (SBRT) Among Medically Inoperable Patients With Early Stage Peripheral Non-small Cell Lung Cancer: An Analysis of RTOG 0236

R. Timmerman, A. Bezjak, J. Bradley, 2012 .

Reply from Authors re: Ronald C. Chen. Decisions Regarding Whether to Use Androgen Deprivation Therapy with Radiotherapy in Prostate Cancer: Is Cardiovascular Mortality the Most Relevant Outcome? Eur Urol 2016;69:211-2: Outcomes for Favorable and Unfavorable Intermediate Risk Prostate Cancer Patient

J. Efstathiou, R. Paulus, J. Voog, 2016, European urology.

Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.

J. Deasy, D. Low, H. Sandler, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cardiovascular mortality following short-term androgen deprivation in clinically localized prostate cancer: An analysis of RTOG 94-08.

Christopher U. Jones, H. Sandler, J. Efstathiou, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Higher BED is Associated with Improved Local-regional Control and Survival for NSCLC Treated with Chemoradiotherapy: An RTOG Analysis

W. Curran, R. Komaki, W. Sause, 2005 .

Cost Effectiveness of Modified Fractionation Radiotherapy versus Conventional Radiotherapy for Unresected Non–Small-Cell Lung Cancer Patients

H. Choy, R. Arriagada, J. Pignon, 2013, Journal of Thoracic Oncology.

Defining Local-Regional Control and Its Importance in Locally Advanced Non-small Cell Lung Carcinoma

W. Curran, H. Choy, J. Bradley, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Treatment of chronic hepatitis C in patients with human immunodeficiency virus (HIV) with weekly peginterferon alpha-2b plus ribavirin: a multi-centred Belgian study.

E. van Marck, I. Colle, H. Van Vlierberghe, 2009, Acta gastro-enterologica Belgica.

Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data

L. Collette, M. Parmar, T. Eisen, 2013, The Lancet. Oncology.

Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

R. Arriagada, J. Pignon, S. Mandrekar, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

W. Curran, R. Komaki, K. Bae, 2012, International journal of radiation oncology, biology, physics.